Targeted Drug Kisqali May Lower Odds for Breast Cancer ' s Return in Some Patients

TUESDAY, June 6, 2023 -- Here ' s some good news for women with the most common type of breast cancer: Adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease, a new...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news